VAERS Explorer
Back to explore

Report #2889632

Received Mar 18, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TYPTYPHOID LIVE ORAL TY21A (VIVOTIF)BERNA BIOTECH, LTD.UNKUnknownPO / MO

Symptoms (1)

Product dose omission issue

Symptom narrative

Patient has missed a dose of Vivotif; Case reference number US-BN-2025-000954 is a spontaneous case initially received from a consumer via Communication (reference number: USBAV25-1151) on 19-May-2025 and concerns a female patient of unspecified age reported as almost 20-years-old. The patient's medical history and concomitant medication details were not provided. On an unspecified date, patient took dose of Vivotif (batch number: unknown), at unknown dose, orally for unknown indication. On an unspecified date, as reported yesterday, the patient missed a dose of Vivotif (explicitly coded as 'missed dose'). At the time of the initial report, it was unknown whether the patient had experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: This case concerns a female patient of unspecified age reported as almost 20-years-old who missed a dose of Vivotif. Product dose omission issue is considered listed per company convention. At this point, it was unknown whether the patient had experienced any adverse events due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: This case concerns a female patient of unspecified age reported as almost 20-years-old who missed a dose of Vivotif. Product dose omission issue is considered listed per company convention. At this point, it was unknown whether the patient had experienced any adverse events due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.

Medical history

Comments: None